FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> Merck

Merck finishes animal vaccine plant overhaul

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


Merck ($MRK) has completed its expansion and renovation of an Elkhorn, NE, animal vaccine plant and will begin transferring researchers from its Delaware site to the newly improved facility. The company has spent $13.5 million renovating the plant, adding a high-speed vaccine vial filling line and disinfection chambers. Story

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Merck